• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi Board Member awarded title for his leadership in Malaysian COVID-19 response

Datuk Dr Noor Hisham Abdullah awarded the distinguished title of ‘Tan Sri’

Home > News

DNDi Board Member awarded title for his leadership in Malaysian COVID-19 response

Datuk Dr Noor Hisham Abdullah awarded the distinguished title of ‘Tan Sri’

Dr noor Hisham Awarded 'Tan Sri' Title
4 Sep 2020

DNDi Board Member and Malaysian Director General of Health, Datuk Dr Noor Hisham Abdullah was awarded the distinguished title of ‘Tan Sri’ on 17 August 2020, in conjunction with the Malaysian King, HRH Al-Sultan Abdullah Ri’ayatuddin Al-Mustafa Billah Shah’s official birthday celebrations.

This honorary royal title was awarded to recognise his leadership and service to the nation in the COVID-19 response. In Malaysia, Tan Sri Dato’ Seri Dr Noor Hisham Abdullah is widely regarded as a dependable, trusted and respectable figure who has helped steer, educate and enforce measures to contain the pandemic.

The title of ‘Tan Sri’ is the second highest civilian honour that can be granted in Malaysia. It is a close equivalent to a British knighthood or Grand Officer de la Legion d’ Honneur, France.

Upon receiving this award, Dr Noor Hisham said, ‘This special recognition also serves as a symbol of appreciation for all frontliners, civil servants and Malaysian Health Ministry staff in the fight against COVID-19.’

In the same week, Tan Sri Dato’ Seri Dr Noor Hisham Abdullah was also named the official annual recipient of the ‘2020/1442 Hijrah Tokoh Maal Hijrah’ (Maal Hijrah Icon Award). The Malaysian King, Sultan Abdullah Ri’ayatuddin Al-Mustafa Billah Shah awarded a medal and a certificate to Tan Sri on behalf of the Malaysian government where the Prime Minister, Tan Sri Muhyiddin Yassin was present to witness this event.

The Maal Hijrah Icon Award is presented yearly to individuals who exemplify noble acts and Islamic stewardship. This award is seen as a recognition by the Malaysian government for their individual and significant contributions in uplifting Islamic values and principles, both nationally and globally.

More information

  • The Star: “Health DG Dr Noor Hisham named national 2020 Tokoh Maal Hijrah”
  • Pejabat Perdana Menteri Malaysia: “Sambutan Maal Hijrah Peringkat Kebangsaan”
  • The Star: “Health DG is this year’s Tokoh Maal Hijrah”

Photo credit: BERNAMA (2020)

Pandemic Preparedness Malaysia

Read, watch, share

Loading...
Publications
15 Jul 2025

DNDi 2024 Annual Report

Healthcare worker attending a training
Press releases
10 Jul 2025

New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease

Woman working in a laboratory
News
10 Jul 2025

LEO Foundation partners with DNDi to develop breakthrough drug discovery model for mycetoma 

Press releases
1 Jul 2025

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment  

Press releases
13 Jun 2025

Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries

Press releases
13 Jun 2025

K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases

News
10 Jun 2025

Bringing life-saving care closer to people living with HIV in Kinshasa 

News
6 Jun 2025

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License